Cite
HARVARD Citation
Fagerli, K. et al. (2019). Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register. Rheumatology. pp. 80-85. [Online].